FindTrial
Sign In

The diagnostic value of Presepsin (soluble CD14 subunit) in predicting sepsis in patients using ATG after renal transplantation

The diagnostic value of Presepsin in predicting sepsis in patients using ATG after renal transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020857
Enrollment
Unknown
Registered
2019-01-21
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection after kidney transplantation

Interventions

Gold Standard:Histopathological or pathogenic microbiological examination
Index test:blood Presepsin

Sponsors

Zhengzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: For patients with clinically confirmed postoperative acute rejection after kidney transplantation, the diagnostic criteria of Sepsis refer to the 2016 international guidelines for the management of Sepsis and septic shock, namely Sepsis 3.0.

Exclusion criteria

Exclusion criteria: No blood samples were obtained within 24 hours of diagnosis, previous history of severe liver disease, age less than 18 years old, over 70 years old, autoimmune disease, lack of clinical data or incomplete study, reluctance to sign a consent form to participate in the study, etc.

Design outcomes

Primary

MeasureTime frame
Presepsin;—

Countries

China

Contacts

Public ContactWang Hongyu

Zhengzhou People's Hospital

hongyu260@163.com+86 13674950311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026